235 related articles for article (PubMed ID: 33760416)
1. [Obesity and COVID-19 : Mechanisms involved in the collusion of two pandemics].
Favre L; Pantet O; Papadimitriou Olivgeris M
Rev Med Suisse; 2021 Mar; 17(731):558-563. PubMed ID: 33760416
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Obesity: Overlapping of Two Pandemics.
Gammone MA; D'Orazio N
Obes Facts; 2021; 14(6):579-585. PubMed ID: 34569546
[TBL] [Abstract][Full Text] [Related]
3. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and obesity: the meeting of two pandemics.
Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
[TBL] [Abstract][Full Text] [Related]
5. [Obesity as a risk factor in COVID-19: Possible mechanisms and implications].
Petrova D; Salamanca-Fernández E; Rodríguez Barranco M; Navarro Pérez P; Jiménez Moleón JJ; Sánchez MJ
Aten Primaria; 2020; 52(7):496-500. PubMed ID: 32586628
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
7. Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action.
Hill MA; Sowers JR; Mantzoros CS
Metabolism; 2021 Jan; 114():154408. PubMed ID: 33080269
[TBL] [Abstract][Full Text] [Related]
8. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
Wang Q; Hu Z
Int J Infect Dis; 2020 Jul; 96():618-620. PubMed ID: 32470601
[TBL] [Abstract][Full Text] [Related]
9. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
10. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
Dalamaga M; Karampela I; Mantzoros CS
Metabolism; 2020 Aug; 109():154282. PubMed ID: 32497535
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 and Obesity: "CoVesity"-a Pandemic Within a Pandemic.
Zakka K; Chidambaram S; Mansour S; Mahawar K; Salminen P; Almino R; Schauer P; Kinross J; Purkayastha S;
Obes Surg; 2021 Apr; 31(4):1745-1754. PubMed ID: 33479921
[TBL] [Abstract][Full Text] [Related]
12. Cytokine Storms: Understanding COVID-19.
Mangalmurti N; Hunter CA
Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
[TBL] [Abstract][Full Text] [Related]
13. Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.
Abiri B; Guest PC; Vafa M
Adv Exp Med Biol; 2021; 1321():97-107. PubMed ID: 33656716
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
15. 2019 Novel Coronavirus Pandemic: What Do We Know?
Margallo LN; Diaz M; Lim PP
S D Med; 2020 Jun; 73(6):262-264. PubMed ID: 32580258
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
Benani A; Ben Mkaddem S
Front Immunol; 2020; 11():1841. PubMed ID: 32793246
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
18. [Obesity, inflammation and COVID-19: preventive interest of ketogenic diet?].
Charlot A; Boumiza R; Roux M; Zoll J
Biol Aujourdhui; 2021; 215(1-2):63-72. PubMed ID: 34397376
[TBL] [Abstract][Full Text] [Related]
19. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
